DOCSLIB.ORG

Ovulation Suppression of Premenstrual Symptoms Using Oral Contraceptives

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ovulation Suppression of Premenstrual Symptoms Using Oral Contraceptives REPORTS Ovulation Suppression of Premenstrual Symptoms Using Oral Contraceptives Patricia J. Sulak, MD Abstract the diagnostic criteria published by the Managing premenstrual symptoms at the most American College of Obstetricians and fundamental level necessitates careful consideration Gynecologists2 for PMS and by the American of female reproductive biology. Inhibiting ovulation Psychiatric Association for PMDD.3 However, using hormonal agents is a reasonable approach for research on premenstrual symptoms in gen- reducing premenstrual symptoms, but the benefits of eral may provide strategies for effective agents such as gonadotropin-releasing hormone ago- treatments for PMS and PMDD. nists and the synthetic androgen danazol are largely offset by their adverse effects and costs. Combination Ovulation Suppression oral contraceptives provide an alternative that is widely accepted by women experiencing premen- Premenstrual symptoms occur almost strual symptoms and by their physicians; and newer exclusively in ovulatory cycles; therefore, formulations with lower levels of estrogen and prog- inhibiting ovulation could be expected to estin, administered using a monthly regimen with a reduce or eliminate these symptoms. shortened pill-free interval, appear promising for Gonadotropin-releasing hormone (GnRH) alleviating patient distress from severe premenstrual agonists can be used to suppress ovulation symptoms. and effectively alleviate premenstrual symp- (Am J Manag Care. 2005;11:S492-S497) toms. However, because using GnRH ago- nists leads to a hypoestrogenic state, he biology of menstrually related “add-back” hormone therapy with estrogen symptoms involves either direct or or estrogen/progesterone is necessary to pre- Tindirect interaction of the ovarian vent menopausal symptoms such as hot cycle with key hormones, neurotransmit- flashes and to minimize bone loss that could ters, or other substances.1 A menstruating occur with steady use.4 These agents are woman may experience symptoms in the costly and are not recommended for long- late luteal phase of her ovulatory cycle term use. throughout her childbearing years. To pro- Another hormonally mediated possibility, vide relief for women who suffer moderately the synthetic androgen danazol, suppresses or severely from any combination of these ovulation as well, but its use is limited by an symptoms, it would seem prudent to seek a array of adverse effects. These include solution that works in tandem with female weight gain; decreased high-density lipopro- physiology to restore health-related quality tein cholesterol, which may increase the of life and an overall sense of well-being with risk of cardiovascular disease; and, at higher the fewest possible adverse effects. doses, the possibility of greater facial hair Symptoms related to the menstrual cycle growth and severity of acne.4 Like GnRH may be limited to mild discomfort or extend agonists, danazol is not recommended for to premenstrual syndrome (PMS) or to long-term use. premenstrual dysphoric disorder (PMDD), Combination oral contraceptives (OCs), which would include severe emotional and which contain estrogen and one of several somatic impairment. Only limited research on alleviation of menstrual symptoms has Address correspondence to: Patricia J. Sulak, MD, Scott & White been conducted to date on women meeting Hospital and Clinic, 2401 S. 31st Street, Temple, TX 76508. S492 THE AMERICAN JOURNAL OF MANAGED CARE DECEMBER 2005 Ovulation Suppression of Premenstrual Symptoms Using Oral Contraceptives progestins, are commonly prescribed hor- start her new pill pack on time. In addition, monal agents providing a variety of noncon- individual women metabolize medications traceptive health benefits, aside from differently, and faster metabolism may jeop- preventing pregnancy. Combination OCs ardize the efficacy of low-dose pills. have been widely used to treat physical pre- menstrual symptoms. Women and their The Standard OC Regimen physicians have a high level of comfort with In studies of women with premenstrual their use, and OC users benefit from their symptoms, OCs have typically been ad- relatively low cost and positive effects on the ministered using a standard regimen (21/7 menstrual cycle. regimen) consisting of 21 days of estrogen- Few controlled trials have evaluated OCs plus-progestin pills, followed by 7 pill-free for their effects on premenstrual symptoms, days (in some regimens, placebo pills may and past studies demonstrated little differ- be taken on pill-free days to increase the ence in the experience of OC users and likelihood of timely resumption). This 21/7 nonusers in this regard.5,6 Evidence for OC regimen closely mimics a woman’s average effects on premenstrual symptoms is weak- 28-day cycle—indeed, the regimen was ened, according to a recent review of the developed with this average cycle in mind— medical literature, by the fact that early and is also used with other contraceptive studies were conducted using OCs with the methods, such as the patch and the vaginal high estrogen doses commonly employed at ring. Women who take hormonal contracep- that time. The reduced estrogen doses in tives using this standard regimen have a current OC formulations may result in a monthly withdrawal bleed that traditionally decreased degree of ovarian inhibition com- has assured them that they are not pregnant. pared with that afforded by older OCs, espe- However, the standard regimen’s 7-day cially during the pill-free interval.7 pill-free interval is associated with signifi- In the female reproductive system, the cant drawbacks. For example, commonly degree of follicular activity during OC use is used low-dose OC formulations have a very dependent on the type and dose of steroids real potential for reduced ovarian inhibition used, the type of regimen, user adherence, during this interval. Also, OC users may and individual metabolic responsiveness to experience an increase in monthly hor- the OC prescribed.7 Early OC formulations mone-withdrawal symptoms—pelvic pain, with high doses of estrogen and progestin headaches, bloating, and breast tender- caused many adverse effects, including nau- ness—during the pill-free interval. sea, breast tenderness, and fluid retention. Hormone-related symptoms were as- These symptoms resulted in a high rate of sessed in a study of women of childbearing premature discontinuation of use, and age who used OCs and kept daily symptom therefore hormone doses in combined OCs diaries.9 Women who requested OCs were have been reduced. OCs inhibit follicular recruited from an obstetrics and gynecology development, and high-dose OCs maintain practice without regard to the presence of steroid levels sufficient to suppress ovarian premenstrual symptoms. Of the 262 evalu- function during the pill-free interval; with able women, 193 were current OC users at low-dose OCs, however, effective serum lev- study entry and 69 women were catego- els of ethinyl estradiol (EE) are maintained rized as new starts because they had had no for only 2 to 3 days after administration is recent OC use (26 had not previously used suspended, and follicular development may OCs and 43 were former OC users). The resume because of inadequate endocrine various low-dose OCs used by the study suppression.8 participants contained 35 µg EE or less as Patient adherence is another crucial fac- the estrogen component plus different pro- tor when low-dose OCs are used. The risk of gestins and were administered in the stan- ovulation is at its maximum during the 7- dard 21/7 regimen. Participants were day pill-free interval, and the risk of preg- significantly more likely to experience hor- nancy increases substantially for a woman mone-withdrawal symptoms during the 7 using these formulations if she does not pill-free days than during the 21 days of VOL. 11, NO. 16, SUP. THE AMERICAN JOURNAL OF MANAGED CARE S493 REPORTS from the effect of estrogen withdrawal on Table 1. Commonly Reported Hormone-withdrawal the vasculature. Symptoms in Women Using OCs Current and new-start OC users both experienced significantly more pelvic pain Hormone or cramps during the pill-free interval than Treatment Pill-free Symptoms (21 days, %) (7 days, %) P Value while taking active pills (each P <.001). In addition, current and new-start OC users Pelvic pain 21 70 <.001 both reported an increase in bloating and Headaches 53 70 <.001 swelling that started during the active-pill week before the pill-free interval. For all Breast tenderness 19 58 <.001 cycles studied, current and new-start OC Bloating/swelling 16 38 <.001 users both reported significantly more bloat- Use of pain medications 43 69 <.001 ing or swelling during the pill-free interval compared with active-pill weeks (58% vs OCs indicates oral contraceptives. 19%, P <.0001). Source: Reference 9. In this study, breast tenderness was also more common in new-start than in current OC users. The current OC users tended to active hormone use. The percentage of experience a greater degree of breast tender- women reporting hormone-withdrawal ness during the week before the pill-free symptoms during the 21 days of pill use interval that peaked during the pill-free and the 7-day pill-free interval is shown interval; 16% experienced breast tenderness in Table 1. during active-pill weeks versus 38% during Women who were current OC users of the pill-free interval (P <.001).9 more than 12 months’ duration experi- enced headaches more commonly during Using a Shorter Pill-free Interval the pill-free interval than during active-pill Low-dose OC formulations provide a less- use. New-start OC users had significantly er degree of ovarian inhibition during the more headaches during the pill-free inter- standard 7-day pill-free interval compared val than during active-pill use in cycle 2 with higher doses.10 Shortening the pill-free (71% vs 49%, P <.001) but not in cycle 1 interval would be logical in an attempt to (71% vs 62%). This increase in the inci- maintain ovulation suppression with low- dence of headaches probably stemmed dose OC formulations.
Load more

Recommended publications
  • Premenstrual Syndrome: a Short Review
    Zdrowie Publiczne i Zarządzanie 2017; 15 (2): 156–160 www.ejournals.eu/Zdrowie-Publiczne-i-Zarzadzanie, doi:10.4467/20842627OZ.17.016.6786 Premenstrual syndrome: A short review Anna Ziomkiewicz-Wichary Zakład Antropologii, Instytut Immunologii i Terapii Doświadczalnej im. L. Hirszfelda Polskiej Akademii Nauk, Wrocław Address for correspondence: Anna Ziomkiewicz-Wichary, Zakład Antropologii, Instytut Immunologii i Terapii Doświadczalnej im. L. Hirszfelda Polskiej Akademii Nauk, 50-449 Wrocław, ul. Podwale 75, phone 71 343 86 75, [email protected] Abstract Premenstrual syndrome (PMS) is a complex cluster of physical and behavioral symptoms that occur during the late luteal phase of the menstrual cycle in reproductive age women. PMS is inextricably associated with ovulation. Not only pregnancy blocks premenstrual symptoms but also in anovulatory cycles symptoms seem to disappear. It is diagnosed in up to 80% women, worldwide, with around 8% of women suffering from its most severe form – premenstrual disphoric disorder. Although this syndrome has been investigated for almost 60 years, researchers are still far from full understanding of this psycho-somatic condition. Some even question its biological basis and attribute it to specific role that women play in western society and culture. This short review summarizes past and current scientific perspective on PMS, including its etiology and physiology. This paper also discusses evolutionary hypotheses proposed to explain the universal occurrence of premenstrual symptoms in women worldwide. Key words: evolutionary explanation, infection, inflammatory proteins, luteal phase, premenstrual disphoric disorder, premenstrual syndrome, progesterone Słowa kluczowe: białka zapalne, faza lutealna, infekcja, progesteron, przedmiesiączkowe zaburzenia dysforyczne, wyjaśnienie ewolucyjne, zespół napięcia przedmiesiączkowego Introduction in estimates of PMS prevalence.
    [Show full text]
  • PREMENSTRUAL DYSPHORIC DISORDER: a Guide for Patients and Families
    PREMENSTRUAL DYSPHORIC DISORDER: A Guide for Patients and Families Margaret L. Moline, PhD, David A. Kahn, MD, Ruth W. Ross, MA, Lee S. Cohen, MD, and Lori L. Altshuler, M.D. www.womensmentalhealth.org Many women experience changes in their bodies or mood before their menstrual flow begins. However, if a woman has moderate or severe symptoms that make it hard for her to function, she may have premenstrual syndrome (PMS) or a more severe condition, premenstrual dysphoric disorder (PMDD). What are PMS and PMDD? Many women experience mild to moderate physical symptoms, such as breast tenderness, pain, or “bloating,” and mild mood changes before their menstrual flow starts. These problems are referred to as PMS. PMDD is a more severe premenstrual condition that affects about 5% of women during their reproductive years. Although PMDD, like PMS, may include physical symptoms, it always involves a worsening of mood that interferes significantly with the woman’s quality of life. In the days before her period, a woman with PMDD may experience moodiness or anger that seems out of control to her. These symptoms may cause her to avoid friends or relatives during the week before her period. Most researchers consider PMDD a type of mood disorder. Mood disorders are biological illnesses caused by changes in brain chemistry. PMDD is not the fault of the woman suffering from it or the result of a “weak” or unstable personality. It is not something that is “all in the woman’s head.” Rather, PMDD is a medical illness that can be treated. 1 www.psychguides.com/index.php What are the symptoms of PMDD? The symptoms of PMDD appear regularly at some time after a woman ovulates in the middle of her monthly cycle.
    [Show full text]
  • PERIMENSTRUAL SYMPTOMS (PS) Occur Immediately
    Women's Health: women experience a marked increase in symptoms The Menstrual Cycle premenses. Cyclic variations in the prevalence of commonly Premenstrual Symptoms: cited perimenstrual symptoms were estimated from Another Look daily symptom recording. A community-based, multiethnic sample of 345 women recorded symptom severity from "not present" to "extreme"for 90 days. NANCY FUGATE WOODS, PhD, RN Maximum total reported symptom score occurred du- ring menses, not- during premenses. When individual Dr. Woods is Professor and Chair, Department of Parent and Child Nursing, University of Washington, Seattle, WA. This symptoms are considered, theprevalence ofthose rated research project was supported by a grant from the Division of as moderate to extreme during menses is less than 15 Nursing, USPHS No. NUO1054. This paper formed the basis of percent. her presentation at the National Conference on Women's Health, held in Bethesda, MD, June 17-18, 1986. A methodfor identifying symptom severity patterns Contributing to this paper were Martha Lentz, PhD, RN; Ellen Sullivan Mitchell, ARNP, PhD; Katherine Lee, PhD, RN; Diana throughout the menstrual cycle is described. Six Taylor, PhD candidate, RN; and Nitsa Allen-Barash, PhD candi- symptom severity patterns were identified. Only 13 date; all of the University of Washington School of Nursing. percent of the women exhibited a pattern of increased symptom severity in the premenses. Another 13 per- Synopsis ......................................................................... cent had a pattern
    [Show full text]
  • British Medical Journal London Saturday May 9 1953
    BRITISH MEDICAL JOURNAL LONDON SATURDAY MAY 9 1953 THE PREMENSTRUAL SYNDROME BY RAYMOND GREENE, D.M., M.R.C.P. Physician, Royal Northern Hospital and New Entd Hospital, Hampstead AND KATHARINA DALTON, M.R.C.S., LR.C.P. General Practitioner, Edmonton, London " Premenstrual tension," as it has hitherto been called, The Literature is the commonest of the minor endocrine disorders. The fact that a large number of women suffer from a variety The first description of the syndrome is that of Frank of symptoms, unpleasant at their mildest and at their (1931). He records a condition of indescribable tension severest incapacitating, during the ultimate seven to ten and a desire to find relief by foolish actions difficult to days of the menstrual cycle is well known; but in this restrain. There were often severe headaches and pal- country very little has been done to alleviate their dis- pable oedema, especially of the face, hands, and feet, tress. This is partly due to the attitude of the patients. accompanied by oliguria and an increase in weight. Just as, before the days of stilboestrol, women in general Sometimes there were diffuse spontaneous subcutaneous accepted the unpleasant symptoms of "the change of haemorrhages, asthma, and, in rare instances, epilepti- life" as a necessary part of the business of being a form seizures. All symptoms were rapidly relieved at woman, so still they pass through one week of discom- the onset of the menstrual flow, but recurred at varying fort in every month, usually without complaining to their times as the end of the cycle drew near.
    [Show full text]
  • Changes Before the Change1.06 MB
    Changes before the Change Perimenopausal bleeding Although some women may abruptly stop having periods leading up to the menopause, many will notice changes in patterns and irregular bleeding. Whilst this can be a natural phase in your life, it may be important to see your healthcare professional to rule out other health conditions if other worrying symptoms occur. For further information visit www.imsociety.org International Menopause Society, PO Box 751, Cornwall TR2 4WD Tel: +44 01726 884 221 Email: [email protected] Changes before the Change Perimenopausal bleeding What is menopause? Strictly defined, menopause is the last menstrual period. It defines the end of a woman’s reproductive years as her ovaries run out of eggs. Now the cells in the ovary are producing less and less hormones and menstruation eventually stops. What is perimenopause? On average, the perimenopause can last one to four years. It is the period of time preceding and just after the menopause itself. In industrialized countries, the median age of onset of the perimenopause is 47.5 years. However, this is highly variable. It is important to note that menopause itself occurs on average at age 51 and can occur between ages 45 to 55. Actually the time to one’s last menstrual period is defined as the perimenopausal transition. Often the transition can even last longer, five to seven years. What hormonal changes occur during the perimenopause? When a woman cycles, she produces two major hormones, Estrogen and Progesterone. Both of these hormones come from the cells surrounding the eggs. Estrogen is needed for the uterine lining to grow and Progesterone is produced when the egg is released at ovulation.
    [Show full text]
  • Premenstrual Syndrome & Premenstrual Dysphoric Disorder
    Premenstrual Syndrome & Premenstrual Dysphoric Disorder Brown Health Services Patient Education Series What is Premenstrual Syndrome? Symptoms of PMDD include: Premenstrual syndrome (PMS) features the ● Anger, irritability presence of physical, behavioral (including affective) ● Internal Tension, anxiety, feeling on edge and cognitive symptoms that recurs in the second ● Mood swings, sudden sadness, increased half of the menstrual cycle (luteal phase) and self-critical thoughts usually resolves within a few days after menses It also includes one or more of the common starts. PMS varies from cycle to cycle and ranges symptoms of PMS. from a mild to severe form. Premenstrual dysphoric disorder (PMDD) is a severe PLEASE CONTACT YOUR PROVIDER IF YOU form of PMS in which symptoms of anger, EXPERIENCE SUICIDAL IDEATION OR ATTEMPTS. irritability, and internal tension are prominent features. It is important to note that the varied symptoms of PMS and PMDD differ between individuals and can be influenced by psychosocial, biological, external What are the common symptoms of and environmental factors. PMS? ● Difficulty concentrating Treatment of PMS ● Change in appetite, food cravings, Mild Symptoms: overeating ● Diminished interest in usual activities ● Drinking plenty of fluids to reduce bloating. ● Eating frequent small meals including whole ● Easy fatigability, decreased energy grains, fresh fruits and vegetables, and ● Feeling overwhelmed or out of control avoiding saturated fats and high salt snack ● Breast tenderness, bloating, weight gain, foods. lower abdomen cramps or joint/muscle ● Complex carbohydrates found in whole aches grains.. ● Sleeping too much or not sleeping enough ● Avoid Alcohol use or misuse ● Headache ● Reduce or eliminate caffeine consumption Other symptoms include: ● Evidence of efficacy is low for vitamins and ● Acne flares dietary supplements, including primrose oil, vitamin B6, vitamin E, calcium, and ● Bowel changes magnesium may be useful although ● Nausea, vomiting evidence is low.
    [Show full text]
  • Managing Pms and Menopause with Exercise and Lifestyle Changes
    MANAGING PMS AND MENOPAUSE WITH EXERCISE AND LIFESTYLE CHANGES In partnership with POTENTRx January 2015 What are PMS and Menopause? PMS, or Premenstrual Syndrome, is pain that occurs in women a few days before the onset of their menstrual cycle due to hormonal changes. Menopause usually begins for women in their 40s or 50s, and marks the end of a women’s natural fertili- ty and menstrual cycles. Frequently Asked Questions: Q: What type of pain/symptoms are tied to PMS and menopause? A: PMS symptoms can include breast tenderness, bloating, cramps, headaches, and/or muscle tenderness. Women can experience some or all of these, at different severity levels. Onset of menopause can be marked by irregular periods; vaginal dryness; hot flashes; night sweats; sleep problems; mood changes; weight gain; slowed metabolism; thinning hair; dry skin; and loss of breast fullness. Q: Why are my PMS symptoms worse than other women? A: Not all women experience PMS symptoms, roughly 3 out of 4 women have had symptoms at least once in their life. Physicians do not know why some women suffer from PMS and others do not. It has been documented that those with family members who experience PMS symptoms are more likely to experience symptoms also. Q: What causes the onset of menopause? A: The onset of menopause can be triggered by multiple things such as the natural decline in reproductive hormones, a hysterectomy, chemotherapy and radiation. Early onset of menopause, or before the age of 40, can be caused by primary ovarian insufficiency, or the inability to produce reproductive hormones due to genetic factors or autoimmune diseases.
    [Show full text]
  • Prevalence of Premenstrual Syndrome and Dysmenorrhoea Among Female Medical Students and Its Association with College Absenteeism * Anandha Lakshmi S
    Int J Biol Med Res. 2011; 2(4): 1011 -1016 Int J Biol Med Res www.biomedscidirect.com Volume 2, Issue 4, Oct 2011 Contents lists available at BioMedSciDirect Publications International Journal of Biological & Medical Research BioMedSciDirect Journal homepage: www.biomedscidirect.com International Journal of Publications BIOLOGICAL AND MEDICAL RESEARCH Original Article Prevalence of Premenstrual Syndrome and Dysmenorrhoea among Female Medical Students and its Association with College Absenteeism * Anandha Lakshmi S. Priy M, Saraswathi I, Saravanan A, Ramamchandran C SRM Medical College Hospital and Research Centre, Kattankulathur, Kanchipuram district- 603 203 A R T I C L E I N F O A B S T R A C T Keywords: Aim and objectives: To evaluate the prevalence of menstrual problem especially dysmenorrhea Body mass index Dysmenorrhoea and pre-menstrual syndrome and its severity in female medical students and its association Menstruation with college absenteeism. Methodology: This is a cross-sectional descriptive study; conducted Premenstrual syndrome on 300 female medical students, all participants were given a questionnaire to complete; Absenteeism questions were related to menstruation elucidating variations in menstrual patterns, history of dysmenorrhea and pre-menstrual syndrome and its severity and absenteeism from college/class; to detect the severity of dysmenorrhea we used the verbal multi-dimensional scoring system, participants were given 20 minutes to complete the questionnaire. Results: The prevalence of dysmenorrhea was 51% and that of the pre-menstrual syndrome was 67%; Only 9.7% of the students consulted a physician or pharmacist. 22.1% of students with dysmenorrhoea reported limitation of daily activities. Increase in BMI is significantly associated with pre-menstrual syndrome (p = 0.035) but its association with dysmenorrhoea was not significant (p = 0.259).
    [Show full text]
  • PATIENT TEACHING AID Premenstrual Dysphoric Disorder TEAR ALONG PERFORATION
    PATIENT TEACHING AID Premenstrual Dysphoric Disorder TEAR ALONG PERFORATION A Severe Type of PMS Premenstrual dysphoric disorder (PMDD) is an intense form of premenstrual syndrome (PMS) distinguished by significant mood changes and physical symptoms during the second half of the menstrual cycle. These symptoms are relieved shortly after menstruation begins, but reappear midway through the next cycle. Some symptoms of PMDD are similar to those of PMS, including physical symptoms like bloating and breast tenderness. However, the emotional symptoms of PMDD resemble major depression (MD): fatigue, hopelessness, suicidal thoughts, lack of interest in daily activities, and poor sleep, as well as anxiety, anger, and irritability. These mood extremes have a disruptive effect on the woman’s life. Although the cause is not clearly understood, PMDD is probably linked to the hormonal fluctuations that occur between ovulation and menstruation—the last 2 weeks of the menstrual cycle. Diagnosis of the condition often is made after examining a daily symptom diary recorded over several months. The fact that PMDD causes serious mood changes not unlike MD makes it important to view the timing of symptoms in relation to the menstrual cycle. A careful history and physical examination can help eliminate other possible causes. Although there is no cure for PMDD, symptoms can be treated, allowing sufferers to lead more nor- mal lives throughout the month. Several medications have been approved for use in the treatment of mood symptoms of PMDD. These include some of the newer antidepressants, such as fluoxetine and sertraline, as well as drospirenone-containing birth control pills to control ovulation.
    [Show full text]
  • Menopause and Depression
    Menopause and Depression Sensitivity to reproductive events In addition to the physical changes (hot flashes, night sweats, and vaginal dryness) that may happen as you transition into menopause, many women experience mood changes, depressive symptoms, and sometimes, severe depression during this time. Although each woman is different, many women have found that they are very sensitive to changes in hormone levels. These women may experience increases in symptoms such as depression and/or anxiety during times of hormone changes, such as during the premenstrual period, pregnancy, and after having a baby (postpartum), as well as during the menopause transition or perimenopause. Like many women, you may find that you are experiencing depressive symptoms as you transition through menopause. Depressive and menopause symptoms Depressive symptoms may include being sad and anxious, not being interested in or enjoying your usual activities, being very tired and lacking energy, experiencing sleep problems and appetite changes, feeling hopeless and worthless, and having thoughts of death or suicide. Depression, which also is described as a major depressive disorder or clinical depression, is a serious disorder that affects your daily life and activities. If you have these symptoms for 2 weeks or longer, you may be diagnosed with depression. It is important to note that not all midlife women experience mood problems, but some women are more vulnerable than others to developing either depressive symptoms or an episode of clinical depression during the menopause transition, especially those women who have had depression previously. The menopause transition is a time of physical and psychological change for many midlife women.
    [Show full text]
  • Management of Premenstrual Syndrome
    Management of Premenstrual Syndrome Green-top Guideline No. 48 November 2016 Please cite this paper as: Management of premenstrual syndrome. BJOG 2016; DOI: 10.1111/1471-0528.14260. DOI: 10.1111/1471-0528.14260 Management of Premenstrual Syndrome This is the second edition of this guideline, which was first published in 2007 under the same title. Executive summary of recommendations How is premenstrual syndrome (PMS) diagnosed? When clinically reviewing women for PMS, symptoms should be recorded prospectively, over two cycles using a symptom diary, as retrospective recall of symptoms is unreliable. A symptom diary should be completed by the patient prior to commencing treatment. Gonadotrophin-releasing hormone (GnRH) analogues may be used for 3 months for a definitive diagnosis if the completed symptom diary alone is inconclusive. [New 2016] What aspects are involved in delivering a service to women with PMS? When should women with PMS be referred to a gynaecologist? Referral to a gynaecologist should be considered when simple measures (e.g. combined oral contraceptives [COCs], vitamin B6, selective serotonin reuptake inhibitors [SSRIs]) have been explored and failed and when the severity of the PMS justifies gynaecological intervention. Who are the key health professionals to manage women with severe PMS? Women with severe PMS may benefit from being managed by a multidisciplinary team comprising a general practitioner, a general gynaecologist or a gynaecologist with a special interest in PMS, a mental health professional (psychiatrist, clinical psychologist or counsellor) and a dietician. [New 2016] How is PMS managed? Are complementary therapies efficacious in treating PMS? fl Women with PMS should be informed that there is con icting evidence to support the use of C some complementary medicines.
    [Show full text]
  • The Creighton Model
    The Creighton Model What is the Creighton Model? The Creighton Model (CrM) is a natural or fertility awareness based method of family planning based on a woman’s observations of her cervical fluid or mucus. Cervical fluid is produced in the woman’s cervix, which is located internally at the opening to her uterus or womb. A woman can use observations of her cervical fluid to identify the fertile and infertile times of her cycle. By observing these changes, couples can decide when to have sexual relations, depending on whether they are trying to achieve or avoid pregnancy. How does the Creighton Model work? During a woman’s reproductive cycle, her body experiences many changes in her hormones that produce observable signs of fertility. Creighton Model practitioners teach couples how to observe and record the quality of the woman’s cervical fluid in a standardized and systematic way. Based on this information, a couple will know when they are fertile and can choose whether or not to have sexual relations based on their family planning goals. When a woman is fertile her cervical fluid becomes clear, stretchy and slippery. If fertile cervical fluid is present, sperm can survive in the woman’s reproductive track and conception can occur for up to 6 days. 1, When ovulation occurs (the ovary releases an egg), the sperm can then join with the egg resulting in pregnancy. After ovulation occurs, the fertile cervical fluid will end and a woman will usually feel dry. If the woman has not become pregnant, she will typically get her period about two weeks later and her cycle will begin again.
    [Show full text]